Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kindler syndrome (KS) is the fourth major type of epidermolysis bullosa (EB), besides simplex, junctional and dystrophic forms, and is characterized by skin fragility and blistering at birth followed by development of photosensitivity and progressive poikilodermatous skin changes.
Features include always present findings: Acral blistering, Reduced epidermal kindlin-1 expression, Poikiloderma, and Dermal atrophy; and very common findings: Visible small blood vessels on skin (telangiectasia of the skin). 24 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 8 | Fragile skin, Acral blistering, Ridged nail |
Digestive system | 2 | Esophageal stenosis, Difficulty swallowing (dysphagia) |
Muscles | 2 | Diffuse skin atrophy, Dermal atrophy |
Eyes | 1 | Corneal erosion |
Brain and nerves | 1 | Difficulty swallowing (dysphagia) |
Blood and immune system | 1 | Oral leukoplakia |
Age of onset: at birth.
Kindler syndrome (KS), a rare subtype of epidermolysis bullosa, is characterized by skin fragility and acral blister formation beginning at birth or in early infancy, diffuse cutaneous atrophy, photosensitivity (most prominent during childhood and usually decreasing after adolescence), poikiloderma, palmoplantar hyperkeratosis, and pseudosyndactyly. Mucosal manifestations are also common and include hemorrhagic mucositis and gingivitis, periodontal disease, premature loss of teeth, and labial leukokeratosis. Other mucosal findings include ectropion, urethral stenosis, and severe phimosis. Severe long-term complications of KS include periodontitis, mucosal strictures, and aggressive squamous cell carcinomas.
Source: GeneReviews — "Kindler Syndrome"
FERMT1 encodes FERM domain containing kindlin 1 (677 aa). Involved in cell adhesion. Contributes to integrin activation. When coexpressed with talin, potentiates activation of ITGA2B. Required for normal keratinocyte proliferation. Highest expression in Adrenal Gland (23.0 TPM) and Esophagus Mucosa (21.2 TPM).
Kindler syndrome is associated with mutations in the FERMT1 gene on chromosome 20.
FERMT1 is classified as a druggable target with score 0.0.
No genotype-phenotype correlations have been identified. Most FERMT1 variants associated with Kindler syndrome are null variants. It has been proposed that FERMT1 pathogenic missense variants and in-frame deletions are associated with milder disease manifestations and later onset of complications .
Source: GeneReviews — "Kindler Syndrome"
No consensus clinical diagnostic criteria for Kindler syndrome (KS) have been published.
KS should be suspected in individuals with the following clinical findings, skin biopsy results, and family history.
Clinical findings
Source: GeneReviews — "Kindler Syndrome"
Before the onset of the photosensitivity and poikiloderma in the first few years of life, Kindler syndrome (KS) is frequently confused with other variants of epidermolysis bullosa (e.g., dystrophic, junctional, and simplex epidermolysis bullosa); however, acral skin atrophy is indicative of KS. Furthermore, in contrast to blistering in other types of epidermolysis bullosa, the blistering in KS significantly improves with age. Disorders of known genetic cause that can exhibit features of poikiloderma but are distinguishable by other clinical features are summarized . Table 3. Disorders with Features of Poikiloderma in the Differential Diagnosis of Kindler Syndrome
Gene(s) | Disorder | MOI | Clinical Characteristics |
|---|---|---|---|
Dyskeratosis congenita | XLADAR | Dysplastic nails, lacy reticular pigmentation of upper chest /or neck. Poikiloderma nail dystrophy occur in late childhood. | Oral leukoplakia. risk for progressive bone marrow failure, myelodysplastic syndrome or acute myelogenous leukemia, solid tumors, pulmonary fibrosis. ANAPC1 RECQL4 |
Rothmund-Thomson syndrome | AR | Rash that typically develops ages 3-6 mos (occasionally as late as age 2 yrs) as erythema, swelling, blistering on face, then spreading to buttocks extremities. Over mos to yrs, rash evolves into poikiloderma. Sparse hair, eyelashes, /or eyebrows. |
Genetic testing for FERMT1 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Kindler syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for Kindler syndrome (KS) have been published. Evaluation Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with KS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with Kindler Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Skin issues | Comprehensive dermatologic eval for skin fragility, blistering, photosensitivity, risk for squamous cell carcinoma | — |
Eyes | Ophthalmologic consult for conjunctival involvement | — |
Mouth | Dental consult for periodontal involvement | GI tract |
counseling | By genetics professionals1 | To inform affected persons families re nature, MOI, implications of KS to facilitate medical personal decision making Family support resources |
Recommended Surveillance for Individuals with Kindler Syndrome System/Concern | Evaluation | Frequency |
Source: GeneReviews — "Kindler Syndrome"
Avoid sun exposure by using sunscreen (SFP 30) and sun-protective clothing.
Source: GeneReviews — "Kindler Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Kindler Syndrome"
View trials for Kindler syndrome
Table 6.
Recommended Surveillance for Individuals with Kindler Syndrome
System/Concern | Evaluation | Frequency
| Screen for premalignant keratoses early squamous cell carcinomas. | Starting in adolescence; annually thereafter
| Screen for oral ulcerations, gingivitis, periodontitis. | Starting in adolescence w/regular dental checkups
Source: GeneReviews — "Kindler Syndrome"
Phenotype severity distribution: 4 always present features, 1 very common feature, 6 common features.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
No clinical trials have been registered for Kindler syndrome.
19 publications have been identified in PubMed for Kindler syndrome. Research spans Case Report / Case Series (53%), Basic Science / Preclinical (16%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 53% |
Laboratory research | 3 | 16% |
Research summaries | 2 | 11% |
Disease patterns and progression | 2 | 11% |
Other research | 1 | 5% |
New treatment approaches | 1 | 5% |
Carrasco G (2026). [PMID: 42091340](https://pubmed.ncbi.nlm.nih.gov/42091340/). *J Dermatol Sci*. [Basic Science / Preclinical]
Hraib M (2025). [PMID: 41189558](https://pubmed.ncbi.nlm.nih.gov/41189558/). *Clinical case reports*. [Epidemiology / Natural History]
Zeng Q (2025). [PMID: 40556416](https://pubmed.ncbi.nlm.nih.gov/40556416/). *Experimental dermatology*. [Epidemiology / Natural History]
Chandrasekaran A (2025). [PMID: 41097738](https://pubmed.ncbi.nlm.nih.gov/41097738/). *Cancers*. [Review / Meta-Analysis]
Khatoon F (2025). [PMID: 40330510](https://pubmed.ncbi.nlm.nih.gov/40330510/). *Journal of lasers in medical sciences*. [Case Report / Case Series]
García-Costa L (2025). [PMID: 40032049](https://pubmed.ncbi.nlm.nih.gov/40032049/). *Enfermeria clinica*. [Gene Therapy / Novel Therapeutics]
Fagan EF (2025). [PMID: 40166845](https://pubmed.ncbi.nlm.nih.gov/40166845/). *Pediatric dermatology*. [Case Report / Case Series]
Ahmad DS (2025). [PMID: 41195192](https://pubmed.ncbi.nlm.nih.gov/41195192/). *Case reports in dermatological medicine*. [Case Report / Case Series]
Aamir M (2025). [PMID: 40438341](https://pubmed.ncbi.nlm.nih.gov/40438341/). *Clinical medicine insights. Case reports*. [Case Report / Case Series]
Klausegger A (2025). [PMID: 40362475](https://pubmed.ncbi.nlm.nih.gov/40362475/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 5:32 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kindler syndrome
Small size; skeletal dental abnormalities; juvenile cataracts; risk for cancer, esp osteosarcoma BLM |
Bloom syndrome | AR | Skin at birth during early infancy appears normal. During 1st or 2nd yr of life, typically following sun exposure, red, sun-sensitive rash appears on nose cheeks (sometimes also on dorsa of hands forearms). | Severe pre- postnatal growth deficiency, highly characteristic sparseness of subcutaneous fat tissue throughout infancy early childhood, short stature throughout postnatal life. Gastroesophageal reflux is common. |
CD151 | KS-like epidermolysis bullosa1 | AR | Facial freckling, poikiloderma, atrophy of skin, acrogeria of backs of hands on sun-exposed areas. Unlike KS, which presents w/blistering during childhood, 1 person described1 presented widespread blistering erosions primarily in pretibial area in adulthood. |
XPC | Xeroderma pigmentosum (XP) | AR | Sun sensitivity w/marked freckle-like pigmentation of face before age 2 yrs. Sunlight-induced ocular involvement. Greatly risk of sunlight-induced cutaneous neoplasms. |
Source: GeneReviews — "Kindler Syndrome"
Screen for premalignant keratoses early squamous cell carcinomas. |
Starting in adolescence; annually thereafter |
Risk for oral mucosa tumors | Screen for oral ulcerations, gingivitis, periodontitis. | Starting in adolescence w/regular dental checkups Agents/Circumstances to Avoid Avoid sun exposure by using sunscreen (SFP 30) and sun-protective clothing. Evaluation of Relatives at Risk See for issues related to testing of at-risk relatives for genetic counseling purposes. |